| Company Name: |
Shanghai EFE Biological Technology Co., Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
info@efebio.com |
| Products Intro: |
Product Name:1-(4-Carboxybutyl)-3,7-dimethylxanthine
CAS:38975-44-9
Purity:97% (HPLC) Package:10mg;25mg
|
| Company Name: |
Henan Vcommend Consultrading Co., Ltd.
|
| Tel: |
13393721940 |
| Email: |
sales@vcommend.com |
| Products Intro: |
Product Name:Pentoxifylline Impurity 11
CAS:38975-44-9
Purity:95.0% Package:10mg;20mg;50mg
|
| Company Name: |
United States Biological
|
| Tel: |
1-800-520-3011 |
| Email: |
sales@advtechind.com |
| Products Intro: |
Product Name:1-(4-Carboxybutyl)-3,7-dimethylxanthine
|
| Company Name: |
CLEARSYNTH LABS LTD.
|
| Tel: |
+91-22-45045900 |
| Email: |
sales@clearsynth.com |
| Products Intro: |
Product Name:"1-(4-Carboxybutyl)-3,7-dimethylxanthine"
CAS:38975-44-9
|
|
| | 1H-Purine-1-pentanoic acid, 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo- Basic information |
| Product Name: | 1H-Purine-1-pentanoic acid, 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo- | | Synonyms: | 1H-Purine-1-pentanoic acid, 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo-;1-(4'-carboxybutyl)-3,7-dimethylxanthine;Pentoxifylline M4;Xanthine Impurity 28;Zopiclone Impurity 35-d8 | | CAS: | 38975-44-9 | | MF: | C12H16N4O4 | | MW: | 280.28 | | EINECS: | | | Product Categories: | | | Mol File: | 38975-44-9.mol |  |
| | 1H-Purine-1-pentanoic acid, 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo- Chemical Properties |
| Melting point | 201 - 203°C | | Boiling point | 571.9±56.0 °C(Predicted) | | density | 1.44±0.1 g/cm3(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 4.69±0.10(Predicted) | | color | White to Off-White |
| | 1H-Purine-1-pentanoic acid, 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo- Usage And Synthesis |
| Uses | 1-(4-Carboxybutyl)-3,7-dimethylxanthine is a main metabolite of Pentoxifylline (P276500); a compound that increases erythrocyte flexibility, reduces blood viscosity, and inhibits platelet aggregation and can thus be used in the treatment of peripheral vascular disease. |
| | 1H-Purine-1-pentanoic acid, 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo- Preparation Products And Raw materials |
|